Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck out, Merck in

This article was originally published in Scrip

Executive Summary

Elmar Schnee, head of Merck KGaA's pharmaceuticals unit, is stepping down to be replaced by the head of emerging markets at US rival Merck & Co, Stefan Oschmann. Mr Schnee was said to be leaving "for personal reasons". In line with his predecessor, Mr Oschmann will be responsible for both the Merck Serono and Consumer Health Care divisions of the German firm. Merck KGaA has suffered a series of clinical setbacks of late. Last month, the US FDA extended its review period for the company's multiple sclerosis pill cladribine, which was rejected by the EU's CHMP in September.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts